Teladoc Health names Michael Grasher chief financial officer, effective immediately
Teladoc Health hired Michael Grasher as its Chief Financial Officer effective August 31, 2026, filling a role that Chief Executive Officer Charles Divita, III had held on an interim basis. Mr. Grasher previously served as CFO of IFG Companies from February 2024 to September 2025 and held CFO roles at Fortegra Group and AMERISAFE, Inc. The filing sets out his base salary, sign-on bonus, equity award and severance terms.
Key points
- Annual base salary of $550,000 and a one-time sign-on bonus of $500,000
- New-hire equity award with an aggregate target value of approximately $3,000,000, expected to be issued September 1, 2026, split 50% restricted stock units and 50% performance stock units
- Annual bonus target of 85% of base salary, beginning with respect to 2027
- Severance if terminated without cause or resigning for good reason outside a change of control: 12 months of base salary; 18 months if within 12 months after a change of control
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 31, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.